| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | 6-phosphofructokinase activity | 1.00e-09 | 3 | 21 | 3 | GO:0003872 | |
| GeneOntologyMolecularFunction | fructose-6-phosphate binding | 1.00e-08 | 5 | 21 | 3 | GO:0070095 | |
| GeneOntologyMolecularFunction | phosphofructokinase activity | 3.50e-08 | 7 | 21 | 3 | GO:0008443 | |
| GeneOntologyMolecularFunction | AMP binding | 1.32e-06 | 21 | 21 | 3 | GO:0016208 | |
| GeneOntologyMolecularFunction | carbohydrate kinase activity | 1.32e-06 | 21 | 21 | 3 | GO:0019200 | |
| GeneOntologyMolecularFunction | fructose binding | 1.58e-05 | 6 | 21 | 2 | GO:0070061 | |
| GeneOntologyMolecularFunction | monosaccharide binding | 1.30e-04 | 95 | 21 | 3 | GO:0048029 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | 7.05e-04 | 709 | 21 | 5 | GO:0016773 | |
| GeneOntologyMolecularFunction | kinase activity | 9.88e-04 | 764 | 21 | 5 | GO:0016301 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | 2.45e-03 | 938 | 21 | 5 | GO:0016772 | |
| GeneOntologyMolecularFunction | carbohydrate binding | 4.01e-03 | 310 | 21 | 3 | GO:0030246 | |
| GeneOntologyBiologicalProcess | fructose 1,6-bisphosphate metabolic process | 7.61e-08 | 9 | 21 | 3 | GO:0030388 | |
| GeneOntologyBiologicalProcess | fructose 6-phosphate metabolic process | 5.05e-07 | 16 | 21 | 3 | GO:0006002 | |
| GeneOntologyBiologicalProcess | NADH regeneration | 1.20e-06 | 21 | 21 | 3 | GO:0006735 | |
| GeneOntologyBiologicalProcess | canonical glycolysis | 1.20e-06 | 21 | 21 | 3 | GO:0061621 | |
| GeneOntologyBiologicalProcess | glucose catabolic process to pyruvate | 1.20e-06 | 21 | 21 | 3 | GO:0061718 | |
| GeneOntologyBiologicalProcess | NAD catabolic process | 2.06e-06 | 25 | 21 | 3 | GO:0019677 | |
| GeneOntologyBiologicalProcess | glycolytic process through glucose-6-phosphate | 2.06e-06 | 25 | 21 | 3 | GO:0061620 | |
| GeneOntologyBiologicalProcess | glycolytic process through fructose-6-phosphate | 4.01e-06 | 31 | 21 | 3 | GO:0061615 | |
| GeneOntologyBiologicalProcess | glucose catabolic process | 4.43e-06 | 32 | 21 | 3 | GO:0006007 | |
| GeneOntologyBiologicalProcess | NADH metabolic process | 1.02e-05 | 42 | 21 | 3 | GO:0006734 | |
| GeneOntologyBiologicalProcess | hexose catabolic process | 2.06e-05 | 53 | 21 | 3 | GO:0019320 | |
| GeneOntologyBiologicalProcess | monosaccharide catabolic process | 2.57e-05 | 57 | 21 | 3 | GO:0046365 | |
| GeneOntologyBiologicalProcess | NAD metabolic process | 5.86e-05 | 75 | 21 | 3 | GO:0019674 | |
| GeneOntologyBiologicalProcess | glycolytic process | 1.83e-04 | 110 | 21 | 3 | GO:0006096 | |
| GeneOntologyBiologicalProcess | ADP catabolic process | 2.03e-04 | 114 | 21 | 3 | GO:0046032 | |
| GeneOntologyBiologicalProcess | purine nucleoside diphosphate catabolic process | 2.20e-04 | 117 | 21 | 3 | GO:0009137 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside diphosphate catabolic process | 2.20e-04 | 117 | 21 | 3 | GO:0009181 | |
| GeneOntologyBiologicalProcess | pyridine nucleotide catabolic process | 2.31e-04 | 119 | 21 | 3 | GO:0019364 | |
| GeneOntologyBiologicalProcess | ADP metabolic process | 2.37e-04 | 120 | 21 | 3 | GO:0046031 | |
| GeneOntologyBiologicalProcess | ribonucleoside diphosphate catabolic process | 2.42e-04 | 121 | 21 | 3 | GO:0009191 | |
| GeneOntologyBiologicalProcess | pyridine-containing compound catabolic process | 2.54e-04 | 123 | 21 | 3 | GO:0072526 | |
| GeneOntologyBiologicalProcess | nucleoside diphosphate catabolic process | 2.61e-04 | 124 | 21 | 3 | GO:0009134 | |
| GeneOntologyBiologicalProcess | carbohydrate phosphorylation | 2.92e-04 | 25 | 21 | 2 | GO:0046835 | |
| GeneOntologyBiologicalProcess | purine nucleoside diphosphate metabolic process | 3.13e-04 | 132 | 21 | 3 | GO:0009135 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside diphosphate metabolic process | 3.13e-04 | 132 | 21 | 3 | GO:0009179 | |
| GeneOntologyBiologicalProcess | pyruvate metabolic process | 3.88e-04 | 142 | 21 | 3 | GO:0006090 | |
| GeneOntologyBiologicalProcess | ribonucleoside diphosphate metabolic process | 3.96e-04 | 143 | 21 | 3 | GO:0009185 | |
| GeneOntologyBiologicalProcess | nucleoside diphosphate metabolic process | 4.47e-04 | 149 | 21 | 3 | GO:0009132 | |
| GeneOntologyBiologicalProcess | purine ribonucleotide catabolic process | 6.45e-04 | 169 | 21 | 3 | GO:0009154 | |
| GeneOntologyBiologicalProcess | ribonucleotide catabolic process | 7.50e-04 | 178 | 21 | 3 | GO:0009261 | |
| GeneOntologyBiologicalProcess | purine nucleotide catabolic process | 7.99e-04 | 182 | 21 | 3 | GO:0006195 | |
| GeneOntologyBiologicalProcess | purine-containing compound catabolic process | 8.78e-04 | 188 | 21 | 3 | GO:0072523 | |
| GeneOntologyBiologicalProcess | carbohydrate catabolic process | 9.91e-04 | 196 | 21 | 3 | GO:0016052 | |
| GeneOntologyBiologicalProcess | pyridine nucleotide metabolic process | 1.08e-03 | 202 | 21 | 3 | GO:0019362 | |
| GeneOntologyBiologicalProcess | nicotinamide nucleotide metabolic process | 1.08e-03 | 202 | 21 | 3 | GO:0046496 | |
| GeneOntologyBiologicalProcess | nucleotide catabolic process | 1.18e-03 | 208 | 21 | 3 | GO:0009166 | |
| GeneOntologyBiologicalProcess | pyridine-containing compound metabolic process | 1.21e-03 | 210 | 21 | 3 | GO:0072524 | |
| GeneOntologyBiologicalProcess | nucleoside phosphate catabolic process | 1.31e-03 | 216 | 21 | 3 | GO:1901292 | |
| GeneOntologyBiologicalProcess | generation of precursor metabolites and energy | 1.81e-03 | 529 | 21 | 4 | GO:0006091 | |
| GeneOntologyBiologicalProcess | glucose metabolic process | 1.86e-03 | 244 | 21 | 3 | GO:0006006 | |
| GeneOntologyBiologicalProcess | ATP metabolic process | 2.15e-03 | 257 | 21 | 3 | GO:0046034 | |
| GeneOntologyBiologicalProcess | fertilization | 2.30e-03 | 263 | 21 | 3 | GO:0009566 | |
| GeneOntologyBiologicalProcess | insulin secretion | 2.58e-03 | 274 | 21 | 3 | GO:0030073 | |
| GeneOntologyBiologicalProcess | organophosphate catabolic process | 2.77e-03 | 281 | 21 | 3 | GO:0046434 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside triphosphate metabolic process | 2.83e-03 | 283 | 21 | 3 | GO:0009205 | |
| GeneOntologyBiologicalProcess | hexose metabolic process | 2.86e-03 | 284 | 21 | 3 | GO:0019318 | |
| GeneOntologyBiologicalProcess | ribonucleoside triphosphate metabolic process | 3.03e-03 | 290 | 21 | 3 | GO:0009199 | |
| GeneOntologyBiologicalProcess | purine nucleoside triphosphate metabolic process | 3.06e-03 | 291 | 21 | 3 | GO:0009144 | |
| GeneOntologyBiologicalProcess | nucleoside triphosphate metabolic process | 3.56e-03 | 307 | 21 | 3 | GO:0009141 | |
| GeneOntologyBiologicalProcess | monosaccharide metabolic process | 3.66e-03 | 310 | 21 | 3 | GO:0005996 | |
| GeneOntologyBiologicalProcess | carbohydrate metabolic process | 3.73e-03 | 646 | 21 | 4 | GO:0005975 | |
| GeneOntologyBiologicalProcess | signal release | 3.88e-03 | 653 | 21 | 4 | GO:0023061 | |
| GeneOntologyBiologicalProcess | carbohydrate derivative catabolic process | 4.11e-03 | 323 | 21 | 3 | GO:1901136 | |
| GeneOntologyBiologicalProcess | peptide hormone secretion | 4.51e-03 | 334 | 21 | 3 | GO:0030072 | |
| GeneOntologyBiologicalProcess | peptide secretion | 4.85e-03 | 343 | 21 | 3 | GO:0002790 | |
| GeneOntologyBiologicalProcess | peptide transport | 5.34e-03 | 355 | 21 | 3 | GO:0015833 | |
| GeneOntologyCellularComponent | 6-phosphofructokinase complex | 7.49e-10 | 3 | 20 | 3 | GO:0005945 | |
| HumanPheno | Elevated circulating aldolase concentration | 2.77e-05 | 9 | 5 | 2 | HP:0012544 | |
| HumanPheno | Exercise-induced myoglobinuria | 5.07e-05 | 12 | 5 | 2 | HP:0008305 | |
| HumanPheno | Abnormal circulating aldolase concentration | 2.48e-04 | 26 | 5 | 2 | HP:0012400 | |
| HumanPheno | Myoglobinuria | 3.54e-04 | 31 | 5 | 2 | HP:0002913 | |
| HumanPheno | Exercise-induced myalgia | 5.06e-04 | 37 | 5 | 2 | HP:0003738 | |
| Domain | ATP_PFK | 1.05e-09 | 3 | 20 | 3 | IPR022953 | |
| Domain | PHOSPHOFRUCTOKINASE | 1.05e-09 | 3 | 20 | 3 | PS00433 | |
| Domain | PFK | 1.05e-09 | 3 | 20 | 3 | PF00365 | |
| Domain | 6-Pfructokinase_euk | 1.05e-09 | 3 | 20 | 3 | IPR009161 | |
| Domain | Phosphofructokinase_dom | 1.05e-09 | 3 | 20 | 3 | IPR000023 | |
| Domain | Phosphofructokinase_CS | 1.05e-09 | 3 | 20 | 3 | IPR015912 | |
| Pathway | BIOCARTA_PTDINS_PATHWAY | 1.36e-06 | 23 | 14 | 3 | M8809 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOLYSIS | 1.77e-06 | 25 | 14 | 3 | M47623 | |
| Pathway | KEGG_GALACTOSE_METABOLISM | 2.00e-06 | 26 | 14 | 3 | M4377 | |
| Pathway | KEGG_PENTOSE_PHOSPHATE_PATHWAY | 2.25e-06 | 27 | 14 | 3 | M1386 | |
| Pathway | KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM | 4.58e-06 | 34 | 14 | 3 | M15898 | |
| Pathway | WP_GLYCOLYSIS_AND_GLUCONEOGENESIS | 1.08e-05 | 45 | 14 | 3 | M39474 | |
| Pathway | WP_GLYCOLYSIS_AND_GLUCONEOGENESIS | 1.58e-05 | 51 | 14 | 3 | MM15928 | |
| Pathway | KEGG_GLYCOLYSIS_GLUCONEOGENESIS | 2.85e-05 | 62 | 14 | 3 | M11521 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 6.59e-05 | 82 | 14 | 3 | MM15394 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 7.34e-05 | 85 | 14 | 3 | M1870 | |
| Pathway | WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS | 7.60e-05 | 86 | 14 | 3 | M39375 | |
| Pathway | WP_METABOLIC_EPILEPTIC_DISORDERS | 9.00e-05 | 91 | 14 | 3 | M48079 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 2.19e-03 | 271 | 14 | 3 | MM15406 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 2.60e-03 | 288 | 14 | 3 | M16864 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | 5.15e-03 | 367 | 14 | 3 | M48346 | |
| Pubmed | 1.90e-10 | 3 | 21 | 3 | 11137296 | ||
| Pubmed | 1.90e-10 | 3 | 21 | 3 | 2960695 | ||
| Pubmed | 1.90e-10 | 3 | 21 | 3 | 33141153 | ||
| Pubmed | 1.90e-10 | 3 | 21 | 3 | 6444721 | ||
| Pubmed | Phosphofructokinase (PFK) isozymes in man. I. Studies of adult human tissues. | 1.90e-10 | 3 | 21 | 3 | 156693 | |
| Pubmed | 1.90e-10 | 3 | 21 | 3 | 7825568 | ||
| Pubmed | 1.90e-10 | 3 | 21 | 3 | 6451249 | ||
| Pubmed | Phosphofructokinase isozyme expression during myoblast differentiation. | 1.90e-10 | 3 | 21 | 3 | 2521854 | |
| Pubmed | 1.54e-07 | 18 | 21 | 3 | 28049690 | ||
| Pubmed | Structures of human phosphofructokinase-1 and atomic basis of cancer-associated mutations. | 3.47e-07 | 2 | 21 | 2 | 25985179 | |
| Pubmed | Insulin specifically regulates expression of liver and muscle phosphofructokinase isoforms. | 3.47e-07 | 2 | 21 | 2 | 29655163 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 8780720 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 2822475 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 6444532 | ||
| Pubmed | The glycolytic enzyme phosphofructokinase-1 assembles into filaments. | 3.47e-07 | 2 | 21 | 2 | 28646105 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 17544406 | ||
| Pubmed | Stabilization of phosphofructokinase 1 platelet isoform by AKT promotes tumorigenesis. | 5.20e-06 | 6 | 21 | 2 | 29038421 | |
| Pubmed | 5.73e-06 | 58 | 21 | 3 | 31067491 | ||
| Pubmed | An analysis of expression patterns of genes encoding proteins with catalytic activities. | 8.87e-06 | 67 | 21 | 3 | 17626619 | |
| Pubmed | 1.25e-05 | 9 | 21 | 2 | 21074528 | ||
| Pubmed | 4.37e-05 | 114 | 21 | 3 | 28245920 | ||
| Pubmed | Physiogenomic comparison of edema and BMI in patients receiving rosiglitazone or pioglitazone. | 4.72e-05 | 117 | 21 | 3 | 18996102 | |
| Pubmed | 5.28e-05 | 18 | 21 | 2 | 19506906 | ||
| Pubmed | 7.24e-05 | 21 | 21 | 2 | 18270970 | ||
| Pubmed | 9.30e-05 | 147 | 21 | 3 | 16959763 | ||
| Pubmed | 1.30e-04 | 28 | 21 | 2 | 19352218 | ||
| Pubmed | Regulation of epidermal differentiation through KDF1-mediated deubiquitination of IKKα. | 1.75e-04 | 182 | 21 | 3 | 32239614 | |
| Pubmed | 2.05e-04 | 192 | 21 | 3 | 20602615 | ||
| Pubmed | 2.54e-04 | 39 | 21 | 2 | 33059001 | ||
| Pubmed | Proteomic identification of brain proteins that interact with dynein light chain LC8. | 2.95e-04 | 42 | 21 | 2 | 14760703 | |
| Pubmed | 4.18e-04 | 50 | 21 | 2 | 23703321 | ||
| Pubmed | 4.51e-04 | 613 | 21 | 4 | 22268729 | ||
| Computational | Glycolysis and TCA cycle. | 3.05e-04 | 26 | 11 | 2 | MODULE_306 | |
| Drug | Uridine diphosphate 2-deoxyglucose | 2.70e-09 | 4 | 21 | 3 | CID000165519 | |
| Drug | AC1MIX9B | 1.35e-08 | 6 | 21 | 3 | CID003081623 | |
| Drug | glipentide | 2.36e-08 | 7 | 21 | 3 | CID000065779 | |
| Drug | dactylarin | 2.36e-08 | 7 | 21 | 3 | CID000161389 | |
| Drug | fructose 2-phosphorothioate 6-phosphate | 1.11e-07 | 11 | 21 | 3 | CID000195184 | |
| Drug | C14:1n-5 | 1.11e-07 | 11 | 21 | 3 | CID000068344 | |
| Drug | M 16209 | 3.05e-07 | 15 | 21 | 3 | CID000164260 | |
| Drug | dibenzyl succinate | 3.76e-07 | 16 | 21 | 3 | CID000007653 | |
| Drug | AC1L1AO2 | 5.47e-07 | 18 | 21 | 3 | CID000001073 | |
| Drug | BRL 26830A | 6.49e-07 | 19 | 21 | 3 | CID006438331 | |
| Drug | 2,3,5-tri-O-benzyl-D-arabinofuranose | 8.10e-07 | 2 | 21 | 2 | CID000255457 | |
| Drug | d-sedoheptulose 1,7-diphosphate | 1.03e-06 | 22 | 21 | 3 | CID000001193 | |
| Drug | AC1L977H | 2.43e-06 | 3 | 21 | 2 | CID000439366 | |
| Drug | 1-o-phosphonohex-2-ulose | 2.43e-06 | 29 | 21 | 3 | CID000000481 | |
| Drug | 2,5-anhydro-D-mannitol | 2.99e-06 | 31 | 21 | 3 | CID000001494 | |
| Drug | Tenax | 3.62e-06 | 33 | 21 | 3 | CID000122082 | |
| Drug | phosphonate analog | 3.62e-06 | 33 | 21 | 3 | CID000475766 | |
| Drug | NSC20266 | 4.38e-06 | 122 | 21 | 4 | CID000000812 | |
| Drug | AC1Q6RZ4 | 4.52e-06 | 123 | 21 | 4 | CID000000719 | |
| Drug | riboxin | 4.73e-06 | 36 | 21 | 3 | CID000006831 | |
| Drug | AC1Q6S7C | 6.05e-06 | 39 | 21 | 3 | CID000000616 | |
| Drug | AC1L494B | 1.54e-05 | 53 | 21 | 3 | CID000181487 | |
| Drug | DB07744 | 1.72e-05 | 55 | 21 | 3 | CID011840941 | |
| Drug | netropsin | 1.82e-05 | 56 | 21 | 3 | CID000004461 | |
| Drug | AC1Q6RZ6 | 2.24e-05 | 60 | 21 | 3 | CID000000609 | |
| Drug | Norethindrone [68-22-4]; Up 200; 13.4uM; HL60; HT_HG-U133A | 2.62e-05 | 192 | 21 | 4 | 2383_UP | |
| Drug | 1,6-di-o-phosphonohexopyranose | 2.72e-05 | 64 | 21 | 3 | CID000000737 | |
| Drug | AC1L19C4 | 3.41e-05 | 69 | 21 | 3 | CID000000483 | |
| Drug | 1-methyl-1,2,3,4-tetrahydroisoquinoline | 3.63e-05 | 10 | 21 | 2 | CID000092214 | |
| Drug | phenylthiocarbamide | 4.55e-05 | 76 | 21 | 3 | CID000676454 | |
| Drug | AC1Q6SXM | 5.11e-05 | 79 | 21 | 3 | CID000000717 | |
| Drug | 2-hexulofuranose | 7.06e-05 | 88 | 21 | 3 | CID000000716 | |
| Drug | Aristolochic Acids | 7.30e-05 | 89 | 21 | 3 | ctd:D034341 | |
| Drug | AC1L1ARE | 7.32e-05 | 14 | 21 | 2 | CID000001116 | |
| Drug | AC1Q6S1N | 8.32e-05 | 93 | 21 | 3 | CID000000290 | |
| Drug | 2-phosphoglycerate | 8.59e-05 | 94 | 21 | 3 | CID000000059 | |
| Drug | acetyl phosphate | 9.72e-05 | 98 | 21 | 3 | CID000000186 | |
| Drug | ochratoxin A | 1.31e-04 | 911 | 21 | 6 | ctd:C025589 | |
| Drug | AC1L1A5Z | 1.41e-04 | 111 | 21 | 3 | CID000000850 | |
| Drug | polyribosylribitol phosphate | 1.44e-04 | 112 | 21 | 3 | CID000002219 | |
| Drug | 3-phosphoglycerate | 1.52e-04 | 114 | 21 | 3 | CID000000724 | |
| Drug | ph 8 | 1.52e-04 | 20 | 21 | 2 | CID000478567 | |
| Drug | acetoacetate | 1.86e-04 | 122 | 21 | 3 | CID000000096 | |
| Drug | fluoropyruvate | 2.03e-04 | 23 | 21 | 2 | CID000067946 | |
| Drug | acadesine | 2.05e-04 | 126 | 21 | 3 | CID000017513 | |
| Drug | manganese-ATP | 2.40e-04 | 25 | 21 | 2 | CID000124341 | |
| Drug | MT20 | 2.60e-04 | 26 | 21 | 2 | CID003025942 | |
| Drug | glyceraldehyde | 2.79e-04 | 140 | 21 | 3 | CID000000751 | |
| Drug | mitiglinide | 2.80e-04 | 27 | 21 | 2 | CID000121891 | |
| Drug | amfonelic acid | 3.24e-04 | 29 | 21 | 2 | CID000002137 | |
| Drug | fructose-1,6-diphosphate sodium salt | 3.48e-04 | 151 | 21 | 3 | CID000000718 | |
| Drug | 55528-53-5 | 3.71e-04 | 31 | 21 | 2 | CID000115146 | |
| Drug | glyceraldehyde-3-phosphate | 4.05e-04 | 159 | 21 | 3 | CID000000729 | |
| Drug | pirenperone | 4.20e-04 | 33 | 21 | 2 | CID000004847 | |
| Drug | phosphomevalonate | 4.20e-04 | 33 | 21 | 2 | CID000000476 | |
| Drug | allulose 6-phosphate | 4.28e-04 | 162 | 21 | 3 | CID000000603 | |
| Drug | benserazide | 4.73e-04 | 35 | 21 | 2 | CID000002327 | |
| Drug | AC1LIZYF | 4.84e-04 | 169 | 21 | 3 | CID000914489 | |
| Drug | cyclopropavir | 5.29e-04 | 37 | 21 | 2 | CID003006048 | |
| Drug | adjunct to levodopa in Parkinsonism | 5.29e-04 | 37 | 21 | 2 | CID000002563 | |
| Drug | glyoxylate | 5.45e-04 | 176 | 21 | 3 | CID000000760 | |
| Drug | beta-hydroxybutyrate | 5.73e-04 | 179 | 21 | 3 | CID000000441 | |
| Drug | phencyclidine | 5.91e-04 | 181 | 21 | 3 | CID000006468 | |
| Drug | 6-o-phosphonohexose | 6.30e-04 | 185 | 21 | 3 | CID000099058 | |
| Drug | Equilin [474-86-2]; Up 200; 15uM; MCF7; HT_HG-U133A | 6.91e-04 | 191 | 21 | 3 | 3377_UP | |
| Drug | Amiodarone hydrochloride [19774-82-4]; Up 200; 5.8uM; MCF7; HT_HG-U133A | 7.13e-04 | 193 | 21 | 3 | 3296_UP | |
| Drug | ara-Hx | 7.13e-04 | 193 | 21 | 3 | CID000000804 | |
| Drug | 2-deoxy-D-ribose-1-phosphate | 7.15e-04 | 43 | 21 | 2 | CID000000634 | |
| Drug | NSD-1015 | 7.15e-04 | 43 | 21 | 2 | CID000001663 | |
| Drug | Sulfadiazine [68-35-9]; Down 200; 16uM; MCF7; HT_HG-U133A | 7.45e-04 | 196 | 21 | 3 | 5523_DN | |
| Drug | Orphenadrine hydrochloride [341-69-5]; Down 200; 13uM; MCF7; HT_HG-U133A | 7.45e-04 | 196 | 21 | 3 | 2318_DN | |
| Drug | Sulfadimethoxine [122-11-2]; Up 200; 12.8uM; PC3; HT_HG-U133A | 7.45e-04 | 196 | 21 | 3 | 7400_UP | |
| Drug | Ethisterone [434-03-7]; Up 200; 12.8uM; HL60; HT_HG-U133A | 7.56e-04 | 197 | 21 | 3 | 2366_UP | |
| Drug | Equilin [474-86-2]; Down 200; 15uM; HL60; HT_HG-U133A | 7.56e-04 | 197 | 21 | 3 | 3039_DN | |
| Drug | tolbutamide | 7.68e-04 | 198 | 21 | 3 | CID000005505 | |
| Drug | Propranolol hydrochloride [318-98-9]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 7.68e-04 | 198 | 21 | 3 | 3396_UP | |
| Drug | Tiabendazole [148-79-8]; Up 200; 19.8uM; HL60; HT_HG-U133A | 7.68e-04 | 198 | 21 | 3 | 2479_UP | |
| Drug | oxaloacetate | 7.68e-04 | 198 | 21 | 3 | CID000000970 | |
| Drug | Primidone [125-33-7]; Up 200; 18.4uM; MCF7; HT_HG-U133A | 7.79e-04 | 199 | 21 | 3 | 3402_UP | |
| Drug | (S)-propranolol hydrochloride [4199-10-4]; Up 200; 13.6uM; PC3; HT_HG-U133A | 7.79e-04 | 199 | 21 | 3 | 6343_UP | |
| Drug | Dibucaine [85-79-0]; Up 200; 11.6uM; PC3; HT_HG-U133A | 7.79e-04 | 199 | 21 | 3 | 4068_UP | |
| Drug | Iobenguane sulfate; Up 200; 10.8uM; HL60; HG-U133A | 7.79e-04 | 199 | 21 | 3 | 1729_UP | |
| Drug | CAY10397; Up 200; 10uM; MCF7; HT_HG-U133A | 7.90e-04 | 200 | 21 | 3 | 7082_UP | |
| Drug | NAN-190 | 8.54e-04 | 47 | 21 | 2 | CID000004431 | |
| Drug | AC1Q7A7H | 8.54e-04 | 47 | 21 | 2 | CID000112184 | |
| Drug | phosphoenolpyruvate | 9.10e-04 | 210 | 21 | 3 | CID000001005 | |
| Drug | sulfonamide analog 1 | 9.48e-04 | 213 | 21 | 3 | CID005327336 | |
| Drug | neotrehalose | 9.61e-04 | 214 | 21 | 3 | CID000001143 | |
| Drug | polyphosphate | 9.66e-04 | 50 | 21 | 2 | CID000000983 | |
| Drug | Phosphoryl | 9.74e-04 | 215 | 21 | 3 | CID006857426 | |
| Drug | DB04618 | 1.01e-03 | 51 | 21 | 2 | CID004369393 | |
| Drug | malate | 1.03e-03 | 219 | 21 | 3 | CID000000525 | |
| Drug | S-adenosyl-D-homocysteine | 1.07e-03 | 222 | 21 | 3 | CID000000193 | |
| Disease | glycogen storage disease (implicated_via_orthology) | 1.06e-09 | 4 | 20 | 3 | DOID:2747 (implicated_via_orthology) | |
| Disease | disease of metabolism (implicated_via_orthology) | 3.51e-07 | 21 | 20 | 3 | DOID:0014667 (implicated_via_orthology) | |
| Disease | Minimal Brain Dysfunction | 1.00e-04 | 22 | 20 | 2 | C1321905 | |
| Disease | Attention Deficit Disorder | 1.00e-04 | 22 | 20 | 2 | C0041671 | |
| Disease | Attention deficit hyperactivity disorder | 1.19e-04 | 24 | 20 | 2 | C1263846 | |
| Disease | Glycogen Storage Disease | 1.52e-04 | 27 | 20 | 2 | C0017919 | |
| Disease | Mood Disorders | 1.92e-04 | 168 | 20 | 3 | C0525045 | |
| Disease | Bipolar Disorder | 2.66e-04 | 477 | 20 | 4 | C0005586 | |
| Disease | airway imaging measurement | 3.02e-04 | 38 | 20 | 2 | EFO_0007627 | |
| Disease | Depression, Neurotic | 3.52e-04 | 41 | 20 | 2 | C0282126 | |
| Disease | Melancholia | 3.52e-04 | 41 | 20 | 2 | C0025193 | |
| Disease | Depressive Syndrome | 3.70e-04 | 42 | 20 | 2 | C0086133 | |
| Disease | Endogenous depression | 4.44e-04 | 46 | 20 | 2 | C0011573 | |
| Disease | pyruvate measurement | 7.53e-04 | 268 | 20 | 3 | EFO_0010117 | |
| Disease | Depressive disorder | 9.37e-04 | 289 | 20 | 3 | C0011581 | |
| Disease | Depression, Bipolar | 1.30e-03 | 79 | 20 | 2 | C0005587 | |
| Disease | Psychotic Disorders | 2.12e-03 | 101 | 20 | 2 | C0033975 | |
| Disease | intraocular pressure measurement | 4.68e-03 | 509 | 20 | 3 | EFO_0004695 | |
| Disease | hemoglobin A1 measurement | 4.96e-03 | 520 | 20 | 3 | EFO_0007629 | |
| Disease | HbA1c measurement | 1.02e-02 | 675 | 20 | 3 | EFO_0004541 | |
| Disease | Mental Depression | 1.27e-02 | 254 | 20 | 2 | C0011570 | |
| Disease | Unipolar Depression | 1.31e-02 | 259 | 20 | 2 | C0041696 | |
| Disease | psoriasis | 1.45e-02 | 273 | 20 | 2 | EFO_0000676 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WYPEVPKCEWETPEG | 531 | P04003 | |
| SWDPWEEPEDAAPVA | 176 | Q96CA5 | |
| LEDEEPDFVPGEWDW | 641 | Q9NVE4 | |
| PDWAHWQELTCDDEP | 116 | Q6ZUJ8 | |
| TEPCPPEWFIGDWLE | 896 | Q9UKP5 | |
| PEERWAWPEVEAPEA | 436 | O95072 | |
| TPWEEDFWEPDVNAE | 201 | P21918 | |
| AARLPEWDEWDPEDE | 51 | Q8N8L6 | |
| RWWVPPDDEDCVSEK | 6 | Q9P298 | |
| WAPLDEWLPPDPEEE | 31 | Q6ZRS4 | |
| PPCDEDWDKDLWEQT | 101 | Q8WW33 | |
| DWLFIPEAPPEDGWE | 226 | P17858 | |
| DWVFIPECPPDDDWE | 226 | P08237 | |
| WVFLPESPPEEGWEE | 236 | Q01813 | |
| AEEELAEFPEPTWPW | 7341 | Q5VST9 | |
| SEEWPDWSEPEEPEN | 526 | Q8IZE3 | |
| RPFPDFDPWWTNDCE | 131 | Q6UWU4 | |
| PDWNEVLPPWDREED | 521 | O15240 | |
| PEPEAPWWEAEEDEE | 251 | Q9BRG2 | |
| IWTEEEELEDVPWFP | 141 | Q8IWU9 | |
| ELTCPPGWEWEDDAW | 966 | Q9NZM1 |